Clinical trials
Phase 2 Waldenstrom Macroglobulinemia trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2002 | 1 |
| 2004 | 1 |
| 2021 | 2 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Active, not recruiting | 2 |
| Recruiting | 1 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Jonsson Comprehensive Cancer Center | 3 |
| Alliance for Clinical Trials in Oncology | 1 |
| BeOne Medicines | 1 |
| Merck Sharp & Dohme LLC | 1 |
| NCIC Clinical Trials Group | 1 |
| Sunnybrook Health Sciences Centre | 1 |
| University of Texas Southwestern Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Waldenstrom Macroglobulinemia | 9 |
| Lymphoma | 7 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 |
| Lymphoma, Follicular | 2 |
| Lymphoma, Non-Hodgkin | 2 |
| Hematologic Neoplasms | 1 |
| Leukemia | 1 |
| Leukemia, B-Cell | 1 |
| Lymphoma, B-Cell, Marginal Zone | 1 |
| Lymphoma, Mantle-Cell | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.